Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
ROIV.OQ - Roivant Sciences Ltd
Roivant Sciences Ltd at Bernstein Strategic Decisions Conference
May 29, 2026 / 12:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome and good morning. Thank you all for joining us. My name is Will Pickering. I cover U.S. biotech at Bernstein. I have the privilege of sharing the stage with Matt Klein, CEO of Roivant. The company has had a remarkable run over the past year, certainly with Brepo as the standout, but far from the only value driver. We'll dig into that and the other assets over the next 50 minutes, but would also like to spend some time on. Bigger picture questions, the Roivant business model, and Matt, your view as an asset hunter about the overall health of the biotech ecosystem today. For those in the audience, please submit your questions through the pigeonhole app so that we can make this as relevant for you as possible
Trustpilot
